Randomized, double-blind phase II study of the matrix metalloprotease (MMP) inhibitor, AG3340 (Prinomastat™) in patients with myelodysplastic syndrome (MDS).

被引:0
|
作者
List, AF
Kurtin, SE
Callander, N
Anderson, JE
Foran, JM
Rabinowitz, I
Glinsmann-Gibson, BJ
Bellamy, WT
Bennett, JM
Collier, M
Mazabel, E
机构
[1] Univ Arizona, Coll Med, Arizona Canc Ctr, Tucson, AZ 85724 USA
[2] Univ Texas, Hlth Sci Ctr, Canc Res & Treatment Ctr, San Antonio, TX USA
[3] Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE USA
[4] Univ New Mexico, Ctr Canc, Div Hematol Oncol, Albuquerque, NM 87131 USA
[5] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14627 USA
[6] Pfizer Pharmaceut Inc, La Jolla, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3119
引用
收藏
页码:789A / 789A
页数:1
相关论文
共 50 条
  • [31] A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
    Howard, James F., Jr.
    Barohn, Richard J.
    Cutter, Gary R.
    Freimer, Miriam
    Juel, Vern C.
    Mozaffar, Tahseen
    Mellion, Michelle L.
    Benatar, Michael G.
    Farrugia, Maria Elena
    Wang, Jing Jing
    Malhotra, Suneil S.
    Kissel, John T.
    MUSCLE & NERVE, 2013, 48 (01) : 76 - 84
  • [32] A randomized, double-blind, placebo-controlled phase II study of ularitide in patients with decompensated congestive heart failure
    Mitrovic, V
    Seferovic, P
    Simeunovic, D
    Miric, M
    Moiseyev, VS
    Kobalava, Z
    Nitsche, K
    Forssmann, WG
    Luss, H
    Meyer, M
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S151 - S151
  • [33] Safety of efalizumab in patients with psoriatic arthritis: Results of a phase II, randomized, double-blind, placebo-controlled study
    Papp, K
    Mease, P
    Garovoy, M
    Zhang, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P156 - P156
  • [34] Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study
    Hong, Soon Jun
    Sung, Ki-Chul
    Lim, Sang-Wook
    Kim, Seok-Yeon
    Kim, Weon
    Shin, Jinho
    Park, Sungha
    Kim, Hae-Young
    Rhee, Moo-Yong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5735 - 5746
  • [35] Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
    Xu, Rui-Hua
    Li, Jin
    Bai, Yuxian
    Xu, Jianming
    Liu, Tianshu
    Shen, Lin
    Wang, Liwei
    Pan, Hongming
    Cao, Junning
    Zhang, Dongsheng
    Fan, Songhua
    Hua, Ye
    Su, Weiguo
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 : 1 - 8
  • [36] Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
    Rui-Hua Xu
    Jin Li
    Yuxian Bai
    Jianming Xu
    Tianshu Liu
    Lin Shen
    Liwei Wang
    Hongming Pan
    Junning Cao
    Dongsheng Zhang
    Songhua Fan
    Ye Hua
    Weiguo Su
    Journal of Hematology & Oncology, 10
  • [37] Primary Results of Stimulus-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition with Sabatolimab Added to Hypomethylating Agents (HMAs) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
    Zeidan, Amer M.
    Ando, Kiyoshi
    Rauzy, Odile
    Turgut, Mehmet
    Wang, Ming-Chung
    Cairoli, Roberto
    Hou, Hsin-An
    Kwong, Yok-Lam
    Sangerman, Montserrat Arnan
    Meers, Stef
    Pullarkat, Vinod A.
    Santini, Valeria
    Malek, Kamel
    Kiertsman, Flavia
    Lyu, Jiaying
    Ramos, Pedro Marques
    Fenaux, Pierre
    Miyazaki, Yasushi
    Platzbecker, Uwe
    BLOOD, 2022, 140 : 2063 - 2065
  • [38] Randomized Phase II Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Patients with Low or Intermediate Risk Myelodysplastic Syndrome (MDS) Receiving Lenalidomide
    Lyons, Roger M.
    Larson, Richard A.
    Kosmo, Michael A.
    Gandhi, Sunil
    Liu, Delong
    Chernoff, Marc
    Dreisbach, Luke
    Matei, Carmen
    Hu, Kuolong
    Franklin, Janet L.
    Berger, Dietmar
    BLOOD, 2009, 114 (22) : 703 - 704
  • [39] Effect of Diamel in patients with metabolic syndrome: A randomized double-blind placebo-controlled study
    Cabrera-Rode, Eduardo
    Orlandi, Neraldo
    Padron, Yaneysi
    Arranz, Celeste
    Olano, Raysa
    Machado, Mayra
    Hernandez-Yero, Arturo
    Calderin, Raul
    Dominguez, Emma
    JOURNAL OF DIABETES, 2013, 5 (02) : 180 - 191
  • [40] Initial effects of kinesio® taping in patients with patellofemoral pain syndrome: A randomized, double-blind study
    Aytar, Aydan
    Ozunlu, Nihan
    Surenkok, Ozgur
    Baltaci, Gul
    Oztop, Pinar
    Karatas, Metin
    ISOKINETICS AND EXERCISE SCIENCE, 2011, 19 (02) : 135 - 142